Dizziness in Norvasc - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Dizziness, when it was recovered, drug effectiveness, race, and more among people who take Norvasc (amlodipine besylate). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.

What is Dizziness?

Dizziness is found to be associated with 3,571 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

293 people who have Dizziness while taking Norvasc were studied.

Severity of Dizziness *:

least: 15.94 %
moderate: 59.36 %
severe: 21.12 %
most severe: 3.59 %

When people recovered from Dizziness *:

while on drug: 5.52 %
after off the drug: 9.66 %
not yet: 84.83 %

Effectiveness of Norvasc *:

not at all: 1.87 %
somewhat: 25.7 %
moderate: 37.85 %
high: 25.23 %
very high: 9.35 %

Race of the people *:

African American, Non-Hispanic: 6.41 %
American Indian/Alaska Native: 0.43 %
Asian: 4.27 %
Hispanic: 2.14 %
Native Hawaiians/Pacific Islanders: 0.43 %
Two or more races: 1.28 %
White, Non-Hispanic: 85.04 %

Time on Norvasc *:

Gender of people when taking Norvasc *:

female: 47.78 %
male: 52.22 %

Age of people when taking Norvasc *:

Conditions people have *:

High Blood Cholesterol: 74 people, 25.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 38 people, 12.97%
Depression: 30 people, 10.24%
Stress And Anxiety: 26 people, 8.87%
Diabetes: 20 people, 6.83%
Insomnia (sleeplessness): 18 people, 6.14%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 16 people, 5.46%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 12 people, 4.10%
Type 2 Diabetes: 11 people, 3.75%
Enlarged Prostate: 11 people, 3.75%

Other drugs people take besides Norvasc *:

Other side effects people have besides Dizziness *:

Fatigue (feeling of tiredness): 45 people, 15.36%
Nausea (feeling of having an urge to vomit): 35 people, 11.95%
Headache (pain in head): 31 people, 10.58%
Breathing Difficulty: 20 people, 6.83%
Chest Pain: 17 people, 5.80%
Stress And Anxiety: 15 people, 5.12%
Weakness: 15 people, 5.12%
Tinnitus (a ringing in the ears): 11 people, 3.75%
Insomnia (sleeplessness): 11 people, 3.75%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 10 people, 3.41%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Dizziness?

Check whether Dizziness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Dizziness in Norvasc

How the study uses the data?

The study is based on amlodipine besylate (the active ingredients of Norvasc). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.